Uncharacterized Protein, Uncharacterized
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | yes | yes: 15 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | no | yes: 8 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 | 
| NetGPI | no | yes: 0, no: 9 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pescher et al. (upgregulation) | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| 
                        
                            Lahav et al. - mRNA 
                            - Protein 
                        
                     | 
                    
Related structures:
AlphaFold database: A4HX38
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 103 | 105 | PF00675 | 0.586 | 
| CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.640 | 
| CLV_NRD_NRD_1 | 312 | 314 | PF00675 | 0.450 | 
| CLV_NRD_NRD_1 | 95 | 97 | PF00675 | 0.566 | 
| CLV_PCSK_KEX2_1 | 102 | 104 | PF00082 | 0.475 | 
| CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.640 | 
| CLV_PCSK_KEX2_1 | 120 | 122 | PF00082 | 0.471 | 
| CLV_PCSK_KEX2_1 | 95 | 97 | PF00082 | 0.458 | 
| CLV_PCSK_PC1ET2_1 | 102 | 104 | PF00082 | 0.457 | 
| CLV_PCSK_PC1ET2_1 | 120 | 122 | PF00082 | 0.471 | 
| CLV_PCSK_PC1ET2_1 | 95 | 97 | PF00082 | 0.435 | 
| CLV_PCSK_SKI1_1 | 191 | 195 | PF00082 | 0.426 | 
| CLV_PCSK_SKI1_1 | 26 | 30 | PF00082 | 0.650 | 
| CLV_PCSK_SKI1_1 | 299 | 303 | PF00082 | 0.440 | 
| CLV_PCSK_SKI1_1 | 313 | 317 | PF00082 | 0.371 | 
| CLV_PCSK_SKI1_1 | 43 | 47 | PF00082 | 0.356 | 
| DOC_MAPK_gen_1 | 146 | 155 | PF00069 | 0.528 | 
| DOC_MAPK_gen_1 | 50 | 58 | PF00069 | 0.551 | 
| DOC_MAPK_MEF2A_6 | 236 | 244 | PF00069 | 0.502 | 
| DOC_PP1_RVXF_1 | 297 | 304 | PF00149 | 0.463 | 
| DOC_USP7_MATH_1 | 36 | 40 | PF00917 | 0.587 | 
| DOC_USP7_UBL2_3 | 120 | 124 | PF12436 | 0.611 | 
| DOC_USP7_UBL2_3 | 146 | 150 | PF12436 | 0.563 | 
| DOC_USP7_UBL2_3 | 187 | 191 | PF12436 | 0.449 | 
| DOC_WW_Pin1_4 | 317 | 322 | PF00397 | 0.559 | 
| LIG_14-3-3_CanoR_1 | 26 | 34 | PF00244 | 0.581 | 
| LIG_14-3-3_CanoR_1 | 3 | 7 | PF00244 | 0.664 | 
| LIG_BRCT_BRCA1_1 | 19 | 23 | PF00533 | 0.637 | 
| LIG_EH1_1 | 223 | 231 | PF00400 | 0.367 | 
| LIG_FHA_1 | 320 | 326 | PF00498 | 0.426 | 
| LIG_FHA_1 | 61 | 67 | PF00498 | 0.482 | 
| LIG_FHA_2 | 139 | 145 | PF00498 | 0.599 | 
| LIG_FHA_2 | 246 | 252 | PF00498 | 0.493 | 
| LIG_LIR_Nem_3 | 33 | 37 | PF02991 | 0.530 | 
| LIG_LIR_Nem_3 | 88 | 92 | PF02991 | 0.509 | 
| LIG_SH2_CRK | 298 | 302 | PF00017 | 0.470 | 
| LIG_SH2_STAP1 | 78 | 82 | PF00017 | 0.489 | 
| LIG_SH2_STAT5 | 283 | 286 | PF00017 | 0.561 | 
| LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.510 | 
| LIG_SH2_STAT5 | 44 | 47 | PF00017 | 0.415 | 
| LIG_SH3_3 | 285 | 291 | PF00018 | 0.492 | 
| LIG_SH3_3 | 298 | 304 | PF00018 | 0.383 | 
| LIG_SUMO_SIM_anti_2 | 328 | 334 | PF11976 | 0.424 | 
| LIG_SUMO_SIM_par_1 | 238 | 243 | PF11976 | 0.552 | 
| LIG_SUMO_SIM_par_1 | 253 | 259 | PF11976 | 0.404 | 
| LIG_SUMO_SIM_par_1 | 328 | 334 | PF11976 | 0.418 | 
| LIG_TRFH_1 | 58 | 62 | PF08558 | 0.544 | 
| LIG_UBA3_1 | 178 | 187 | PF00899 | 0.429 | 
| LIG_WRC_WIRS_1 | 338 | 343 | PF05994 | 0.421 | 
| MOD_CK1_1 | 17 | 23 | PF00069 | 0.652 | 
| MOD_CK1_1 | 243 | 249 | PF00069 | 0.528 | 
| MOD_CK1_1 | 39 | 45 | PF00069 | 0.456 | 
| MOD_CK2_1 | 138 | 144 | PF00069 | 0.584 | 
| MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.540 | 
| MOD_GlcNHglycan | 162 | 165 | PF01048 | 0.452 | 
| MOD_GlcNHglycan | 226 | 229 | PF01048 | 0.498 | 
| MOD_GlcNHglycan | 248 | 251 | PF01048 | 0.360 | 
| MOD_GlcNHglycan | 271 | 274 | PF01048 | 0.535 | 
| MOD_GlcNHglycan | 335 | 338 | PF01048 | 0.416 | 
| MOD_GlcNHglycan | 7 | 10 | PF01048 | 0.624 | 
| MOD_GSK3_1 | 220 | 227 | PF00069 | 0.450 | 
| MOD_GSK3_1 | 32 | 39 | PF00069 | 0.569 | 
| MOD_GSK3_1 | 333 | 340 | PF00069 | 0.443 | 
| MOD_GSK3_1 | 7 | 14 | PF00069 | 0.637 | 
| MOD_N-GLC_1 | 199 | 204 | PF02516 | 0.514 | 
| MOD_N-GLC_1 | 224 | 229 | PF02516 | 0.490 | 
| MOD_NEK2_1 | 189 | 194 | PF00069 | 0.378 | 
| MOD_NEK2_1 | 224 | 229 | PF00069 | 0.458 | 
| MOD_NEK2_1 | 333 | 338 | PF00069 | 0.492 | 
| MOD_NEK2_1 | 341 | 346 | PF00069 | 0.349 | 
| MOD_NEK2_1 | 7 | 12 | PF00069 | 0.619 | 
| MOD_PKA_2 | 11 | 17 | PF00069 | 0.595 | 
| MOD_PKA_2 | 2 | 8 | PF00069 | 0.632 | 
| MOD_PKA_2 | 235 | 241 | PF00069 | 0.389 | 
| MOD_Plk_1 | 224 | 230 | PF00069 | 0.510 | 
| MOD_Plk_1 | 240 | 246 | PF00069 | 0.364 | 
| MOD_Plk_1 | 32 | 38 | PF00069 | 0.522 | 
| MOD_Plk_4 | 148 | 154 | PF00069 | 0.598 | 
| MOD_Plk_4 | 2 | 8 | PF00069 | 0.651 | 
| MOD_Plk_4 | 235 | 241 | PF00069 | 0.465 | 
| MOD_ProDKin_1 | 317 | 323 | PF00069 | 0.555 | 
| MOD_SUMO_for_1 | 286 | 289 | PF00179 | 0.573 | 
| MOD_SUMO_rev_2 | 249 | 255 | PF00179 | 0.346 | 
| TRG_DiLeu_BaEn_2 | 84 | 90 | PF01217 | 0.531 | 
| TRG_ENDOCYTIC_2 | 298 | 301 | PF00928 | 0.476 | 
| TRG_ENDOCYTIC_2 | 335 | 338 | PF00928 | 0.486 | 
| TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.492 | 
| TRG_ER_diArg_1 | 11 | 13 | PF00400 | 0.625 | 
| TRG_ER_diArg_1 | 49 | 52 | PF00400 | 0.420 | 
| TRG_NES_CRM1_1 | 144 | 156 | PF08389 | 0.563 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N1PBL8 | Leptomonas seymouri | 63% | 69% | 
| A0A1X0NYW3 | Trypanosomatidae | 42% | 100% | 
| A0A3R7JY16 | Trypanosoma rangeli | 36% | 94% | 
| A0A3S7WU51 | Leishmania donovani | 100% | 100% | 
| A4H8S0 | Leishmania braziliensis | 81% | 100% | 
| E9AQV4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% | 
| Q4QEM4 | Leishmania major | 95% | 100% | 
| V5BMN4 | Trypanosoma cruzi | 40% | 96% |